Plant Impactwww.plantimpact.com TICKER: PIM EXCHANGE: L
Plant Impact specialises in plant stress relief solving the problems of abiotic stress arising from temperature, salinity, drought and light. They develop and market yield-enhancing crop nutrition and protection products, notably the calcium absorption aid, CaT, and the nitrogen delivery product PiNT. The environmentally-friendly pesticide BugOil has been licensed to Arysta LifeScience, with sales expected when the product completes the regulatory approval process running through 2011-2012. PI's objective is to minimise inputs whilst maximising quality output in a way that is environmentally sustainable.
Plant Impact has been pursuing its strategy of forming strategic partnerships to accelerate the commercialisation of its proven technologies. This includes a significant agreement with Arysta LifeScience (February 2010) for the evaluation, development and distribution of crop nutrient products.
Evaluation, development and distribution agreements have also been made with Agrimatco (September 2010) and Cebeco (November 2010). These three well-chosen strategic partners can be expected to hasten Plant Impact‟s commercialisation timeline.
A DCF analysis assuming a 20% discount rate and a conservative long term growth rate of 1% yields a target price of 58p, a modest reduction from our former target of 60p.
The environmentally friendly pesticide BugOil® has been licensed to Arysta LifeScience, with sales expected soon after completing the regulatory approval process.
This year has seen successful trial results and the commencement of significant new field trials in broad acre and arable crops. With an expanding number of distributors and key partnerships, the company is well positioned to address multi-billion dollar markets.
Arysta LifeScience has significantly expanded its relationship, extending Plant Impact's territorial coverage from 24 to 52 countries.
Potato production a huge global market: field trial results show substantial increase in yield and numbers grown
Trading update reports results likely to be in line with management expectations
We retain target fair value of 60p / share versus current 23p